Molnar-Institute - Pharma Technology Focus | Issue 118 | May 2022

DryLab^®4: Empower™ Automated.

One-Click Batch Creation. Enhanced Modeling Performance

The 4-Step Design Space Modeling Workflow

Waters Empower™ + Instrumentation

Waters Empower™ + Instrumentation

Design Space Modeling in 4 Simple Steps

Empower Automated

DryLab. Chromatographic Retention Modeling since 1986

02/24/2024 15:58:54

Home | Tackling insulin prices
In this issue
CSafe Global
Contents
Mimotopes Company Insight
Mimotopes
Briefing
Industry news
The pharma industry briefing
Covid-19 executive briefing by GlobalData
Molnar-Institute Company Insight
Molnar-Institute
Comment
Why did the cannabis industry blossom during the pandemic?
Negative AdCom vote for Amylyx’s ALS drug AMX0035, but hope remains
Will Russia’s invasion affect biopharmaceutical licensing agreements?
Fall from grace? What 2022 may have in stock for biopharmaceutical SPACs
BEA Technologies
In Depth
Insulin pricing: could an e-commerce approach cut costs?
Bacteria and balance: how understanding the vaginal microbiome can help discover new drugs
Big pharma’s gradual retreat on clinical trials in Russia
Covid-19, flu combo vaccines an advance but with rollout quandaries
FDA shows unease about marketing approval applications based on single-country t
In Data
How big is the gender pay gap in the pharma industry in Britain?
Where is trade most likely to be disrupted in pharma from the Russian invasion o
Big data innovation among pharma companies dropped off in the last quarter
Event: Outsourcing in Clinical Trials Europe 2022
Events
Next issue

04/26/2022 00:00:00